Implementing Diversity, Equity, and Inclusion in Drug Development

Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.

EP: 1.Diversity Plans in Action: How to Boost Inclusivity in Trials Faster and for the Long Term

Now Viewing

EP: 2. Implementing Diversity, Equity, and Inclusion in Drug Development

Recent Videos